Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: The experience of the National Cancer Institute of Milano

Citation
E. Leo et al., Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: The experience of the National Cancer Institute of Milano, ANN SURG O, 7(2), 2000, pp. 125-132
Citations number
42
Categorie Soggetti
Oncology
Journal title
ANNALS OF SURGICAL ONCOLOGY
ISSN journal
10689265 → ACNP
Volume
7
Issue
2
Year of publication
2000
Pages
125 - 132
Database
ISI
SICI code
1068-9265(200003)7:2<125:TRRACM>2.0.ZU;2-N
Abstract
Background: At present, abdominoperineal resection remains the most diffuse method of treatment of very low rectal cancer. Today, we can avoid this me thod in some patients by using a sphincter-saving procedure. Methods: From March 1990 to January 1999, 273 consecutive total rectal rese ctions and coloendoanal anastomoses were performed at our Institute; this s tudy concerns 141 consecutive patients treated for a primary adenocarcinoma of the distal rectum, from 3.5 to 8 cm from the anal verge. Patient strati fication, based on definitive pathological report, was 31 Dukes' stage A (T 2N0), 44 stage B (T3N0), and 66 stage C (T2N+-T3N+). Results: Overall recurrence rate was 9.2%; postoperative morbidity attribut able to the procedure was low. A perfect continence was documented in 61% o f cases. The only pathological factor related to local recurrence rate is p eritumoral lymphocytic reaction inside and around the tumor (P = .0005 and .031) independently from the number of metastatic lymph nodes, depth of fat ty tissue infiltration, and lymphatic and venous neoplastic emboli. The min imum follow-up time is 12 months. Conclusions: Our data, in accordance with other authors, seem to highlight the relevant role that a well-practiced surgery, together with accurate inf ormation on the spreading of this disease, has in achieving an optimal loca l control of cancer.